262 related articles for article (PubMed ID: 30257991)
21. Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.
De Nicolo A; Parisini E; Zhong Q; Dalla Palma M; Stoeckert KA; Domchek SM; Nathanson KL; Caligo MA; Vidal M; Cusick ME; Garber JE
Cancer Res; 2009 Sep; 69(17):7030-7. PubMed ID: 19706752
[TBL] [Abstract][Full Text] [Related]
22. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
Rodriguez M; Yu X; Chen J; Songyang Z
J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
[TBL] [Abstract][Full Text] [Related]
23. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
24. The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.
Adamovich AI; Diabate M; Banerjee T; Nagy G; Smith N; Duncan K; Mendoza Mendoza E; Prida G; Freitas MA; Starita LM; Parvin JD
Am J Hum Genet; 2022 Apr; 109(4):618-630. PubMed ID: 35196514
[TBL] [Abstract][Full Text] [Related]
25. Functional Analyses of Rare Germline Missense
Hovland HN; Mchaina EK; Høberg-Vetti H; Ariansen SL; Sjursen W; Van Ghelue M; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833189
[TBL] [Abstract][Full Text] [Related]
26. Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.
Lodovichi S; Vitello M; Cervelli T; Galli A
Cell Cycle; 2016 Oct; 15(20):2723-31. PubMed ID: 27484786
[TBL] [Abstract][Full Text] [Related]
27. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.
Iofrida C; Melissari E; Mariotti V; Guglielmi C; Guidugli L; Caligo MA; Pellegrini S
BMC Cancer; 2012 May; 12():207. PubMed ID: 22646717
[TBL] [Abstract][Full Text] [Related]
28. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
Shiozaki EN; Gu L; Yan N; Shi Y
Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
[TBL] [Abstract][Full Text] [Related]
29. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
Manke IA; Lowery DM; Nguyen A; Yaffe MB
Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
[TBL] [Abstract][Full Text] [Related]
30. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
31. Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain.
Glover JN
Fam Cancer; 2006; 5(1):89-93. PubMed ID: 16528612
[TBL] [Abstract][Full Text] [Related]
32. Toward classification of BRCA1 missense variants using a biophysical approach.
Rowling PJ; Cook R; Itzhaki LS
J Biol Chem; 2010 Jun; 285(26):20080-7. PubMed ID: 20378548
[TBL] [Abstract][Full Text] [Related]
33. Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage.
Nelson AC; Holt JT
Radiat Res; 2010 Jul; 174(1):1-13. PubMed ID: 20681793
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
Liu X; Ladias JA
Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
[TBL] [Abstract][Full Text] [Related]
36. MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.
Maresca L; Spugnesi L; Lodovichi S; Cozzani C; Naccarato AG; Tancredi M; Collavoli A; Falaschi E; Rossetti E; Aretini P; Cervelli T; Galli A; Caligo MA
Eur J Med Genet; 2015 Oct; 58(10):531-9. PubMed ID: 26381082
[TBL] [Abstract][Full Text] [Related]
37. Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling.
Periasamy J; Kurdekar V; Jasti S; Nijaguna MB; Boggaram S; Hurakadli MA; Raina D; Kurup LM; Chintha C; Manjunath K; Goyal A; Sadasivam G; Bharatham K; Padigaru M; Potluri V; Venkitaraman AR
Cell Chem Biol; 2018 Jun; 25(6):677-690.e12. PubMed ID: 29606576
[TBL] [Abstract][Full Text] [Related]
38. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
[TBL] [Abstract][Full Text] [Related]
39. Functional and structural analysis of C-terminal BRCA1 missense variants.
Quiles F; Fernández-Rodríguez J; Mosca R; Feliubadaló L; Tornero E; Brunet J; Blanco I; Capellá G; Pujana MÀ; Aloy P; Monteiro A; Lázaro C
PLoS One; 2013; 8(4):e61302. PubMed ID: 23613828
[TBL] [Abstract][Full Text] [Related]
40. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
Williams RS; Glover JN
J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]